Faraz Ali - 17 Nov 2026 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

SEC form
4
Accepted by SEC
18 Nov 2026, 20:18:06 UTC
Prior SEC filing
11 Sep 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Faraz Ali filed Form 4 for Tenaya Therapeutics, Inc. (TNYA) on 18 Nov 2026.

Key facts

  • This page summarizes Faraz Ali's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Nov 2026, 20:18.

Change

  • Previous filing in this sequence was filed on 11 Sep 2026.
  • Current net transaction value: -$1,122.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001667937 Primary reporting owner

Ali Faraz

Relationship
Chief Executive Officer, Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNYA transaction

Common Stock

Sale

Transaction value
-$1,122
Shares
-3,499
Change %
-0.65%
Price
$0.3208
Shares after
536,283
Date
17 Nov 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025. Such sales were automatic and not at the discretion of the Reporting Person.

Footnote F2

Includes 375,463 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .